MELD-Na Score Calculator
Enter serum bilirubin, creatinine, INR, and sodium to compute the MELD-Na score and estimate 90-day mortality risk in liver disease.
Use the MELD-Na Score Calculator
Lab Values
Minimum applied: 1.0 mg/dL per UNOS guidelines
Capped at 4.0 mg/dL; dialysis patients use 4.0
Minimum applied: 1.0 per UNOS guidelines
Formula clamps to 125–137 mEq/L range
MELD-Na Formula (UNOS 2016)
If initial MELD > 11: MELD-Na = MELD + 1.32×(137−Na) − [0.033×MELD×(137−Na)]; otherwise no sodium adjustment
Enter lab values on the left and click Calculate MELD-Na Score
MELD-Na Score (UNOS Allocation)
—
—
—
Classic MELD
—
Without sodium
Na Adjustment
—
Points added by sodium
Score Position
Step-by-Step Breakdown
90-Day Mortality Reference (MELD-Na)
| Score Range | Severity | ~90-Day Mortality |
|---|
Clinical note: This tool is for educational and reference purposes only. MELD-Na scores guide transplant allocation policy and are not a substitute for full clinical evaluation, multidisciplinary hepatology review, or transplant center protocols. Mortality estimates are population-based approximations. Always confirm results with laboratory-reported values and clinical judgment.
Summary
This tool reproduces the MELD-Na formula adopted by OPTN in January 2016 and replaced by MELD 3.0 in July 2023. It is intended for historical comparison and education, not current U.S. allocation decisions.
How it works
- Enter the most recent serum bilirubin (mg/dL) from a metabolic panel.
- Enter serum creatinine (mg/dL); enter 4.0 if the patient is on hemodialysis.
- Enter the INR from a coagulation panel.
- Enter serum sodium (mEq/L); the formula clamps values to the 125–137 range.
- Click Calculate to compute both MELD and MELD-Na scores with a full breakdown.
- Review the severity category, estimated mortality, and the step-by-step formula output.
Use cases
- Estimate 90-day waitlist mortality for patients with cirrhosis or end-stage liver disease.
- Reproduce historical MELD-Na values from records or older studies.
- Identify patients whose serum hyponatremia significantly increases mortality risk beyond the classic MELD.
- Track serial MELD-Na scores to monitor disease progression over hospitalizations.
- Support TIPS (transjugular intrahepatic portosystemic shunt) patient selection.
- Educate patients and families about liver disease severity with an objective, guideline-referenced score.
- Compare MELD vs. MELD-Na to quantify the sodium penalty in hyponatremic patients.
- Compare the former 2016 calculation with newer scoring approaches.